While the potential of PET-MRI is increasingly being explored in the clinical setting, preclinical PET-MRI is only slowly leaving the proof-of-concept stage, which may be explained by technical difficulties due to the size-constraints and strong magnetic fields used in preclinical MRI. In the current work, we present results from a first in vivo application of 18F-FDG PET-MRI using a retrofitted micro-PET detector in a commercial 9.4T magnet. We studied the twitcher mouse model of Krabbe disease, in which an altered glucose metabolism had been suggested.
This abstract and the presentation materials are available to members only; a login is required.